Michael Leuchten
Stock Analyst at Jefferies
(0.33)
# 4,400
Out of 4,649 analysts
574
Total ratings
48.7%
Success rate
-4%
Average return
Main Sectors:
Stocks Rated by Michael Leuchten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: GSK GSK plc | Maintained: Buy | 2,500p | 1,818p | +37.55% | 47 | Aug 11, 2026 | |
| ETR: BAYN Bayer Aktiengesellschaft | Maintained: Hold | €46.00 | €47.79 | -3.75% | 96 | Aug 10, 2026 | |
| LON: AZN AstraZeneca PLC | Maintained: Buy | 17,500p | 11,460p | +52.71% | 103 | Aug 7, 2026 | |
| EPA: SAN Sanofi | Maintained: Buy | €100.00 | €75.52 | +32.42% | 22 | Aug 7, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | kr 285.00 | kr 294.70 | -3.29% | 72 | Aug 4, 2026 | |
| LON: 0NZT UCB SA | Upgraded: Hold | €212.00 → €220.00 | €215.55 | +2.07% | 3 | Aug 3, 2026 | |
| SWX: NOVN Novartis AG | Maintained: Hold | CHF 110.00 | CHF 122.44 | -10.16% | 14 | Jul 21, 2026 | |
| SWX: ROP Roche Holding AG | Maintained: Sell | CHF 230.00 | CHF 355.10 | -35.23% | 70 | Jun 8, 2026 | |
| GSK GSK plc | Maintained: Buy | $56 → $67 | $49.52 | +35.50% | 4 | May 29, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Maintained: Buy | €470.00 | €237.50 | n/a | 42 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €208.00 | €136.30 | n/a | 40 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €108.00 → €113.00 | €156.00 | n/a | 11 | Jun 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €420.00 → €390.00 | €185.50 | n/a | 10 | Jun 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 2,650p | 3,320p | n/a | 1 | Oct 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $45.89 | n/a | 20 | Jun 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €400.00 | €190.00 | n/a | 6 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €83.00 → €80.00 | €41.04 | n/a | 4 | Nov 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 75.00 → CHF 85.00 | CHF 60.68 | n/a | 6 | Aug 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $43.72 | n/a | 1 | May 12, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $150.88 | n/a | 2 | Apr 22, 2016 |
GSK plc
Aug 11, 2026
Maintained: Buy
Price Target: 2,500p
Current: 1,818p
Upside: +37.55%
Bayer Aktiengesellschaft
Aug 10, 2026
Maintained: Hold
Price Target: €46.00
Current: €47.79
Upside: -3.75%
AstraZeneca PLC
Aug 7, 2026
Maintained: Buy
Price Target: 17,500p
Current: 11,460p
Upside: +52.71%
Sanofi
Aug 7, 2026
Maintained: Buy
Price Target: €100.00
Current: €75.52
Upside: +32.42%
Novo Nordisk A/S
Aug 4, 2026
Maintained: Hold
Price Target: kr 285.00
Current: kr 294.70
Upside: -3.29%
UCB SA
Aug 3, 2026
Upgraded: Hold
Price Target: €212.00 → €220.00
Current: €215.55
Upside: +2.07%
Novartis AG
Jul 21, 2026
Maintained: Hold
Price Target: CHF 110.00
Current: CHF 122.44
Upside: -10.16%
Roche Holding AG
Jun 8, 2026
Maintained: Sell
Price Target: CHF 230.00
Current: CHF 355.10
Upside: -35.23%
GSK plc
May 29, 2026
Maintained: Buy
Price Target: $56 → $67
Current: $49.52
Upside: +35.50%
Sartorius Aktiengesellschaft
Aug 21, 2023
Maintained: Buy
Price Target: €470.00
Current: €237.50
Upside: n/a
Aug 4, 2023
Maintained: Buy
Price Target: €208.00
Current: €136.30
Upside: n/a
Jun 30, 2023
Maintained: Hold
Price Target: €108.00 → €113.00
Current: €156.00
Upside: n/a
Jun 19, 2023
Maintained: Buy
Price Target: €420.00 → €390.00
Current: €185.50
Upside: n/a
Oct 10, 2022
Maintained: Buy
Price Target: 2,650p
Current: 3,320p
Upside: n/a
Jun 28, 2022
Downgraded: Sell
Price Target: n/a
Current: $45.89
Upside: n/a
Feb 28, 2022
Maintained: Sell
Price Target: €400.00
Current: €190.00
Upside: n/a
Nov 4, 2021
Maintained: Buy
Price Target: €83.00 → €80.00
Current: €41.04
Upside: n/a
Aug 23, 2021
Maintained: Buy
Price Target: CHF 75.00 → CHF 85.00
Current: CHF 60.68
Upside: n/a
May 12, 2016
Upgraded: Buy
Price Target: n/a
Current: $43.72
Upside: n/a
Apr 22, 2016
Upgraded: Hold
Price Target: n/a
Current: $150.88
Upside: n/a